2021 Midyear Outlook: Navigating through the recovery
Listen in as we discuss our outlook on the US recovery and the Federal Reserve’s new framework, including its impact on inflation, interest rates and growth.
|Net Asset Value (NAV)||$16.03|
|Daily NAV Change||$0.14||0.88%|
|Weekly NAV Change||$0.61||3.96%|
|Public Offering Price (POP)||$16.03||—|
|Fund Type||Domestic Equity|
|Fiscal Year End||September|
|Dividends Paid||March, June, September, December|
(as of 11/30/2021)
|Total Equity Holdings
(as of 11/30/2021)
(as of 11/30/2021)
|Portfolio Turnover Rate
(as of 9/30/2021)
|Morningstar Category||Large Value|
|Benchmark||S&P 500 Dividend Aristocrats Index|
Data quoted is past performance and current performance may be lower or higher. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost.
Performance does not include the effect of sales charges as Class R shares are not subject to sales charges. Performance prior to the Class R inception date is based on the performance of the Fund's Class A shares, adjusted to reflect the sales charge structure associated with Class R shares.
|Fund at NAV||15.94%||17.63%||13.06%||N/A||N/A||12.58%|
|S&P 500 Dividend Aristocrats Index||17.37%||19.24%||14.54%||14.32%||14.78%||-|
|Fund at NAV||11.66%||24.14%||11.31%||N/A||N/A||12.13%|
|S&P 500 Dividend Aristocrats Index||12.77%||25.82%||12.74%||13.13%||15.54%||-|
|Morningstar Large Value||16.30%||34.79%||9.62%||11.14%||12.72%||-|
|S&P 500 Dividend Aristocrats Index||-2.73||27.97||8.68|
Category: Large Value
|Overall out of 1146|
|3 Year out of 1146|
Ratings are based on risk-adjusted returns.
Category: Large Value
|1 Year||1077 /1205||88|
|3 Year||249 /1146||25|
Morningstar Ranking / # of Funds in Category displays the fund's actual rank within its Morningstar Category based on average annual total return and number of Funds in that Category. The Morningstar Percentile Ranking compares a Fund's Morningstar risk and return scores with all the Funds in the same Category, where 1% = Best and 100% = Worst.
|Date||Price||Dividend Reinvest Date||Capital Gain Reinvest Date|
|Ex-date||Income||Capital Gains||Reinvest Gains||Payment Date|
The table includes the daily prices at NAV (net asset value) for the history of this fund's selected share class. NAV is the amount per share you would receive if you sold shares that day.
|A. O. Smith Corp.||1.84%|
|W.W. Grainger, Inc.||W.W. Grainger, Inc., offers maintenance, repair and operating supplies and other related products and services through local branches, catalogs and the Internet. Its products include material handling equipment, safety and security supplies, lighting and electrical products, power and hand tools, pumps and plumbing supplies and many other products. The company also provides inventory management and energy efficiency solutions. It was founded in 1927 and is headquartered in Lake Forest, IL.||1.72%|
|Sherwin-Williams Co. (The)||The Sherwin-Williams Company manufactures, distributes, and sells paints, coatings, and related products. The Company's products are sold to professional, industrial, commercial, and retail customers primarily in North and South America. Sherwin Williams also has additional operations in the Caribbean region, Europe, and Asia.||1.68%|
|Lowe's Co., Inc.||Lowe's Co., Inc., is a retailer of home improvement products for maintenance, repair, remodeling, home decorating, and property maintenance. Lowe's was founded in 1946 and is headquartered in Mooresville, NC.||1.66%|
|McCormick & Co., Inc.||McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments and other flavorful products to the food industry worldwide.||1.66%|
|Automatic Data Processing, Inc.||1.65%|
|Franklin Resources, Inc.||Franklin Resources, Inc. provides investment advisory services to mutual fund, retirement, institutional, and separate accounts investors. The Company manages various asset classes including global equity, global institutional and municipal fixed income, money funds, alternative investments, and hedge funds.||1.65%|
|AbbVie, Inc.||AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.||1.64%|
|West Pharmaceutical Services, Inc.||1.63%|
Total Portfolio Holdings DOWNLOAD (as of 9/30/2021)updated quarterly, upon availability
|Large ( > $10 bil)||95.6%|
|Medium ($2 - $10 bil)||4.3%|
|Small ( < $2 bil)||0.0%|
|Median Market Cap (as of 11/30/2021)||$43.8 bil|
|Health Care Equipment||4.4%|
|Packaged Foods & Meats||3.2%|
|Asset Management & Custody Banks||3.2%|
|Domestic Common Stock||92.40%|
|Foreign Common Stock||7.38%|
|Cash and Cash Equivalents||0.22%|
|Statement of Additional Information||DOWNLOAD|
Significant Event* On September 13, 2021, the Board of Trustees (Board) of the Ivy Funds approved the Fund name change to “Delaware Ivy S&P 500 Dividend Aristocrats Index Fund” (formerly Delaware Ivy ProShare S&P 500 Dividend Aristocrats Index Fund, and before that, Ivy ProShares S&P 500 Dividend Aristocrats Index Fund) and the appointment of the portfolio manager team of Barry Gladstein, CFA, and Chris Gowlland, CFA, of Delaware Management Company (DMC) as new Fund portfolio managers. In addition, the Board approved appointing Macquarie Funds Management Hong Kong Limited and Macquarie Investment Management Global Limited to provide discretionary investment management services in a sub-advisory capacity. The Board also approved the termination of the Fund’s current sub-advisor. In connection with these changes, the Board approved applicable revisions to the Fund’s investment strategies. All changes took effect on or about November 15, 2021.Data quoted is past performance and current performance may be lower or higher. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost.